Skip to main content

International Journal of Clinical Oncology

Ausgabe 3/2014

Inhalt (13 Artikel)

Review Article

Update of molecular pathobiology in oral cancer: a review

Tomonori Sasahira, Tadaaki Kirita, Hiroki Kuniyasu

Original Article

Boron neutron capture therapy for advanced salivary gland carcinoma in head and neck

Teruhito Aihara, Norimasa Morita, Nobuhiko Kamitani, Hiroaki Kumada, Koji Ono, Junichi Hiratsuka, Tamotu Harada

Original Article

Predictive factors that influence the course of medullary thyroid carcinoma

Kalliopi Pazaitou-Panayiotou, Alexandra Chrisoulidou, Stylianos Mandanas, Konstantinos Tziomalos, Eleni Doumala, Frideriki Patakiouta

Original Article

Orally administered S-1 suppresses circulating endothelial cell counts in metastatic breast cancer patients

Wakako Tsuji, Hiroshi Ishiguro, Sunao Tanaka, Megumi Takeuchi, Takayuki Ueno, Masakazu Toi

Original Article

Breast conservation therapy for ductal carcinoma in situ (DCIS): does presentation of disease affect long-term outcomes?

Harrison X. Bai, Sabin B. Motwani, Susan A. Higgins, Bruce G. Haffty, Lynn D. Wilson, Donald R. Lannin, Suzanne B. Evans, Meena S. Moran

Original Article

Intraoperative diagnosis of lymph node metastasis by transcription–reverse transcription concerted reaction assay in gastric cancer

Ryouichi Hirayama, Akiyoshi Seshimo, Kunitomo Miyake, Masako Nishizawa, Shingo Kameoka

Original Article

Carcinoma of unknown primary with gastrointestinal profile: immunohistochemistry and survival data for this favorable subset

G. R. Varadhachary, S. Karanth, W. Qiao, H. R. Carlson, M. N. Raber, J. D. Hainsworth, F. A. Greco

Original Article

A single-center analysis of the survival benefits of adjuvant gemcitabine chemotherapy for biliary tract cancer

Kenya Yamanaka, Etsuro Hatano, Masashi Kanai, Shiro Tanaka, Keiichi Yamamoto, Masato Narita, Hiromitsu Nagata, Takamichi Ishii, Takahumi Machimoto, Kojiro Taura, Shinji Uemoto

Original Article

Improvement of prognosis in patients with metastatic renal cell carcinoma and Memorial Sloan-Kettering Cancer Center intermediate risk features by modern strategy including molecular-targeted therapy in clinical practice

Tomomi Kamba, Toshinari Yamasaki, Satoshi Teramukai, Noboru Shibasaki, Ryuichiro Arakaki, Hiromasa Sakamoto, Yoshiyuki Matsui, Kazutoshi Okubo, Koji Yoshimura, Osamu Ogawa

Original Article

Gemcitabine and docetaxel, an effective second-line chemotherapy for lung metastasis of urothelial carcinoma

Taku Naiki, Noriyasu Kawai, Yoshihiro Hashimoto, Takehiko Okamura, Ryosuke Ando, Takahiro Yasui, Atsushi Okada, Toshiki Etani, Keiichi Tozawa, Kenjiro Kohri

Original Article

Surveillance biopsy and active treatment during active surveillance for low-risk prostate cancer

Katsuyoshi Hashine, Hiroyuki Iio, Yoshiteru Ueno, Shohei Tsukimori, Iku Ninomiya

Original Article

High incidence of regional and in-transit lymph node metastasis in patients with alveolar rhabdomyosarcoma

Yoshihiro Nishida, Satoshi Tsukushi, Hiroshi Urakawa, Hideshi Sugiura, Hiroatsu Nakashima, Yoshihisa Yamada, Naoki Ishiguro

Original Article

NRAS mutations in primary and metastatic melanomas of Japanese patients

Hisashi Uhara, Atsuko Ashida, Hiroshi Koga, Eisaku Ogawa, Aya Uchiyama, Ryuhei Uchiyama, Koichi Hayashi, Yukiko Kiniwa, Ryuhei Okuyama

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.